Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (DCM)

Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (DCM)

US Patent 6994970 · Granted Feb 7, 2006

Estimated economic value: $2,409,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Eicosanoid derivatives2022
CYP-eicosanoid derivatives2021
Eicosanoid derivatives2019
Use of aptamers in therapy and/or diagnosis of autoimmune diseases2019
Use of aptamers in therapy and/or diagnosis of autoimmune diseases2018
Peptides having binding affinity to an antibody which recognizes an epitope on a2017
Peptides having binding affinity to an antibody which recognizes an epitope on a2017
Eicosanoid derivatives2016
Use of aptamers in therapy and/or diagnosis of autoimmune diseases2016
Peptides having binding affinity to an antibody which recognizes an epitope on a2013
Peptides having binding affinity to an antibody which recognizes an epitope on a2013
Peptides against autoantibodies causing intolerance to cold and use thereof2013